Stocks › AVXL
ANAVEX LIFE SCIENCES CORP.
AVXL·Nasdaq·
United States·USD
United States·USD$1.60
-0.04 (-2.74%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
AVXL
ANAVEX LIFE SCIENCES CORP. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AVXLS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of AVXL by members of U.S. Congress · 2 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Christopher L. JacobsHouse · R · NY |
AVXLANAVEX LIFE SCIENCES CORP. · Stock |
Sale $1,001 - $15,000 |
Jan 20, 2023 | Dec 12, 2022 | Filing ↗ |
| Christopher L. JacobsHouse · R · NY |
AVXLANAVEX LIFE SCIENCES CORP. · Stock |
Purchase $1,001 - $15,000 |
Nov 16, 2022 | Oct 12, 2022 | Filing ↗ |
Whale Activity
Position changes in AVXL reported for 2026-06-30 by 9 tracked institutional filers
- Increased4
- New2
- Held0
- Decreased2
- Closed1
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 8.1M | $20.9M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.1M | $10.5M | increased |
| TWO SIGMA INVESTMENTS, LP | 3.0M | $7.9M | decreased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 948.6K | $2.5M | increased |
| CITADEL ADVISORS LLC | 329.1K | $852K | decreased |
| Point72 Asset Management, L.P. | 157.5K | $408K | new |
| D. E. Shaw & Co., Inc. | 115.5K | $299K | increased |
| MILLENNIUM MANAGEMENT LLC | 60.5K | $157K | new |
| Renaissance Technologies | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by AVXL insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
96 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| MISSLING CHRISTOPHER UPresident and CEO · Director | Tax withholding | −145.0K | $9.58 | $1.4M | Sep 11, 2025 | Form 4 ↗ |
| MISSLING CHRISTOPHER UPresident and CEO · Director | Option exercise | +187.5K | $5.04 | $945K | Sep 11, 2025 | Form 4 ↗ |
| Thomas SteffenDirector | Tax withholding | −11.3K | $7.75 | $88K | Jun 5, 2025 | Form 4 ↗ |
| Thomas SteffenDirector | Option exercise | +50.0K | $1.76 | $88K | Jun 5, 2025 | Form 4 ↗ |
| MISSLING CHRISTOPHER UPresident and CEO · Director | Tax withholding | −282.5K | $9.63 | $2.7M | Mar 24, 2025 | Form 4 ↗ |
| MISSLING CHRISTOPHER UPresident and CEO · Director | Option exercise | +500.0K | $0.92 | $460K | Mar 24, 2025 | Form 4 ↗ |
| Donhauser Peter D.O.Director | Purchase | +2,835 | $3.64 | $10K | Jun 14, 2024 | Form 4 ↗ |
| Thomas SteffenDirector | Purchase | +5,000 | $4.52 | $23K | May 15, 2024 | Form 4 ↗ |
| MISSLING CHRISTOPHER UPresident and CEO · Director | Sale | −73.4K | $5.11 | $375K | Mar 28, 2024 | Form 4 ↗ |
| MISSLING CHRISTOPHER UPresident and CEO · Director | Option exercise | +73.4K | $1.32 | $97K | Mar 28, 2024 | Form 4 ↗ |
| MISSLING CHRISTOPHER UPresident and CEO · Director | Option exercise | +232.0K | $1.60 | $371K | Jun 29, 2023 | Form 4 ↗ |
| MISSLING CHRISTOPHER UPresident and CEO · Director | Sale | −268.0K | $7.98 | $2.1M | Jun 28, 2023 | Form 4 ↗ |
| MISSLING CHRISTOPHER UPresident and CEO · Director | Option exercise | +268.0K | $1.60 | $429K | Jun 28, 2023 | Form 4 ↗ |
| Skarpelos AthanasiosDirector | Sale | −50.0K | $9.06 | $453K | May 25, 2022 | Form 4 ↗ |
| Skarpelos AthanasiosDirector | Option exercise | +50.0K | $0.92 | $46K | May 25, 2022 | Form 4 ↗ |
| MISSLING CHRISTOPHER UPresident and CEO · Director | Sale | −51.6K | $26.00 | $1.3M | Jun 29, 2021 | Form 4 ↗ |
| MISSLING CHRISTOPHER UPresident and CEO · Director | Option exercise | +51.6K | $1.32 | $68K | Jun 29, 2021 | Form 4 ↗ |
| Boenisch SandraPFO and Treasurer | Sale | −166.7K | $26.53 | $4.4M | Jun 29, 2021 | Form 4 ↗ |
| Boenisch SandraPFO and Treasurer | Option exercise | +35.0K | $5.92 | $207K | Jun 29, 2021 | Form 4 ↗ |
| Boenisch SandraPFO and Treasurer | Option exercise | +106.7K | $3.28 | $350K | Jun 29, 2021 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding AVXL · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 2.7M | $8.1M | 0.11% | Mar 31, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.9M | $7.6M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 2.4M | $6.3M | 0.01% | Jun 30, 2026 |
| Federated Hermes MDT Small Cap Core Fund Federated Hermes MDT Series | 2.0M | $5.6M | 0.25% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 1.0M | $2.8M | 0.01% | Jul 31, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.0M | $2.7M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF iShares Trust | 737.5K | $1.9M | 0.01% | Jun 30, 2026 |
| iShares Biotechnology ETF iShares Trust | 631.7K | $1.6M | 0.02% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 484.7K | $1.5M | 0.00% | May 31, 2026 |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 450.3K | $1.4M | 0.01% | May 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list AVXL's shares (CUSIP 032797300), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 4.7M shares5.0%
Jul 31, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming anavex life sciences as client
Government Contracts
Federal awards to ANAVEX LIFE SCIENCES CORP. · USAspending
No federal contract awards found for ANAVEX LIFE SCIENCES CORP..
U.S. Patents
Recent USPTO applications naming ANAVEX LIFE SCIENCES CORP.
No USPTO patent applications found for ANAVEX LIFE SCIENCES CORP..
Annual Financials
From AVXL's 10-K filings · XBRL
No annual XBRL figures on record for AVXL. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 1-for-4Reverse splitOct 7, 2015
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 5.01, 5.07Change in control · Shareholder voteSep 28, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsSep 9, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsSep 2, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 25, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureAug 17, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureAug 11, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureAug 3, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 30, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsJul 20, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsJun 26, 2026
EDGAR ↗
About ANAVEX LIFE SCIENCES CORP.
From SEC EDGAR company records
Overview and Strategy Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (“CNS”) diseases with high unmet need. We analyze genomic data from clinical trials to identify biomarkers, which we use in the analysis of our clinical trials. The Company’s focus is on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Our research and development pipeline includes ANAVEX®2-73 currently in thre…
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersNEW YORK, NY
SEC CIK0001314052 ↗
Former namesThrifty Printing Inc.